Abstract
Biological protein-based entities that form nanostructures ranging from 8 to 50 nm in size represent promising candidates in the development of novel immunotherapeutics against cancer and microbial pathogens. These recombinant nanoparticles usually consist of major coat or core proteins derived from viruses like for instance papillomavirus, polyomavirus, parvovirus or hepatitis B virus that spontaneously assemble into these highly ordered, supramolecular, icosahedral structures. By genetic engineering of permissive sites or cross-linking to surface-exposed subunit domains these nanoparticles successfully serve as carrier matrix with per se adjuvant activity for the delivery of appropriate guest peptides, protein fragments and complete proteins. Using this nanobiotechnology, potent humoral and cell-mediated immunity with emphasis on CD4 and CD8 T cell responses are induced against self or non-self foreign antigens representing appropriate immunostimulatory epitopes or complete proteins of microbial pathogens or tumor-associated antigens. Breaking of T and B cell tolerance required for therapeutic interventions against cancer represents the hallmark of such an outstanding antigen delivery system. In combination with the increasing identification of validated target antigens from pathogens or tumors, and promising progress in bioprocess development, such nanostructures offer novel homologous or heterologous treatment and prevention opportunities against a variety of malignant and infectious diseases.
Keywords: Virus-like-particles, Antigen delivery, Vaccines, Infectious diseases, Cancer and Nanobiotechnology
Current Nanoscience
Title: Heterologous Virus-Like-Particles: Recombinant Nanosystems as Versatile Antigen Delivery Devices for Immune Intervention
Volume: 2 Issue: 4
Author(s): Christoph Reichel, Marc Brinkman, Claus Ruehland, Christian O. A. Reiser and Juergen Hess
Affiliation:
Keywords: Virus-like-particles, Antigen delivery, Vaccines, Infectious diseases, Cancer and Nanobiotechnology
Abstract: Biological protein-based entities that form nanostructures ranging from 8 to 50 nm in size represent promising candidates in the development of novel immunotherapeutics against cancer and microbial pathogens. These recombinant nanoparticles usually consist of major coat or core proteins derived from viruses like for instance papillomavirus, polyomavirus, parvovirus or hepatitis B virus that spontaneously assemble into these highly ordered, supramolecular, icosahedral structures. By genetic engineering of permissive sites or cross-linking to surface-exposed subunit domains these nanoparticles successfully serve as carrier matrix with per se adjuvant activity for the delivery of appropriate guest peptides, protein fragments and complete proteins. Using this nanobiotechnology, potent humoral and cell-mediated immunity with emphasis on CD4 and CD8 T cell responses are induced against self or non-self foreign antigens representing appropriate immunostimulatory epitopes or complete proteins of microbial pathogens or tumor-associated antigens. Breaking of T and B cell tolerance required for therapeutic interventions against cancer represents the hallmark of such an outstanding antigen delivery system. In combination with the increasing identification of validated target antigens from pathogens or tumors, and promising progress in bioprocess development, such nanostructures offer novel homologous or heterologous treatment and prevention opportunities against a variety of malignant and infectious diseases.
Export Options
About this article
Cite this article as:
Reichel Christoph, Brinkman Marc, Ruehland Claus, A. Reiser O. Christian and Hess Juergen, Heterologous Virus-Like-Particles: Recombinant Nanosystems as Versatile Antigen Delivery Devices for Immune Intervention, Current Nanoscience 2006; 2 (4) . https://dx.doi.org/10.2174/157341306778699338
DOI https://dx.doi.org/10.2174/157341306778699338 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
Current Cancer Drug Targets The Anti-Breast Cancer Effects of Green-Synthesized Zinc Oxide Nanoparticles Using Carob Extracts
Anti-Cancer Agents in Medicinal Chemistry Radionuclide Imaging in Drug Development
Current Pharmaceutical Design miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke
MicroRNA TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design Na+-H+ Exchanger, pH Regulation and Cancer
Recent Patents on Anti-Cancer Drug Discovery Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review
Current Cancer Drug Targets Nanoformulations of Coumarins and the Hybrid Molecules of Coumarins with Potential Anticancer Effects
Anti-Cancer Agents in Medicinal Chemistry ATP-Binding Cassette Efflux Transporters in Human Placenta
Current Pharmaceutical Biotechnology MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review
Current Cancer Drug Targets CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology
Current Gene Therapy Targeting Cellular Proapoptotic Molecules for Developing Anticancer Agents from Marine Sources
Current Drug Targets Transition Metal Based Anticancer Drugs
Current Topics in Medicinal Chemistry The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Current Drug Targets Recent Advances in Copper Radiopharmaceuticals
Current Radiopharmaceuticals The Search for a Topical Dual Action Spermicide/Microbicide
Current Medicinal Chemistry Synthesis and Evaluation of 99mTc Chelate-conjugated Bevacizumab
Current Radiopharmaceuticals Influence of Dietary Substances on Intestinal Drug Metabolism and Transport
Current Drug Metabolism Cytostatic and Apoptotic Effects of DNMT and HDAC Inhibitors in Endometrial Cancer Cells
Current Pharmaceutical Design